Atlas Trials

A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia

Clinical trial NCT02595528 · COMPLETED

Trial details

NCT number
NCT02595528
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Presbyopia
Start date
2016-04-29
Primary completion
2017-10-18
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.